{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Palsy+Supranuclear", "query": { "condition": "Palsy Supranuclear" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 87, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Palsy+Supranuclear&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T17:10:48.377Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00382824", "title": "Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Progressive Supranuclear Palsy" ], "interventions": [ { "name": "Coenzyme Q10", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Lahey Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 61, "start_date": "2006-09", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2019-08-01", "last_synced_at": "2026-09-02T17:10:48.377Z", "location_count": 3, "location_summary": "Birmingham, Alabama • Boston, Massachusetts • Burlington, Massachusetts", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Burlington", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00382824" }, { "nct_id": "NCT04993768", "title": "A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Progressive Supranuclear Palsy" ], "interventions": [ { "name": "TPN-101, 100 mg/day", "type": "DRUG" }, { "name": "TPN-101, 200 mg/day", "type": "DRUG" }, { "name": "TPN-101, 400 mg/day", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Transposon Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "41 Years", "maximum_age": "86 Years", "sex": "ALL", "summary": "41 Years to 86 Years" }, "enrollment_count": 42, "start_date": "2021-12-12", "completion_date": "2024-03-24", "has_results": false, "last_update_posted_date": "2026-04-08", "last_synced_at": "2026-09-02T17:10:48.377Z", "location_count": 14, "location_summary": "Phoenix, Arizona • La Jolla, California • San Francisco, California + 11 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04993768" }, { "nct_id": "NCT03924414", "title": "Trial of Parkinson's And Zoledronic Acid", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Parkinson Disease", "Osteoporosis", "Parkinsonism", "Parkinson's Disease and Parkinsonism", "Atypical Parkinsonism", "Progressive Supranuclear Palsy", "Multiple System Atrophy", "Vascular Parkinsonism", "Dementia With Lewy Bodies" ], "interventions": [ { "name": "Zoledronic Acid 5Mg/Bag 100Ml Inj", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "California Pacific Medical Center Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 2721, "start_date": "2019-11-15", "completion_date": "2026-02-28", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-09-02T17:10:48.377Z", "location_count": 77, "location_summary": "Scottsdale, Arizona • Fayetteville, Arkansas • Little Rock, Arkansas + 58 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Berkeley", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03924414" }, { "nct_id": "NCT03724136", "title": "Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer Disease", "Alzheimer Dementia", "Vascular Dementia", "Lewy Body Disease", "Lewy Body Dementia With Behavioral Disturbance (Disorder)", "Dementia, Mixed", "Parkinson-Dementia Syndrome", "Chronic Traumatic Encephalopathy", "Huntington's Dementia", "Wernicke Korsakoff Syndrome", "Traumatic Brain Injury", "Dementia, Multi-Infarct", "Autism", "Autism Spectrum Disorder", "Autistic Behavior", "Autistic Disorder, Current or Active State", "Cadasil", "LATE Limbic-predominant Age-related TDP-43 Encephalopathy" ], "interventions": [ { "name": "Intravenous Bone Marrow Stem Cell (BMSC) Fraction", "type": "PROCEDURE" }, { "name": "Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction", "type": "PROCEDURE" }, { "name": "Near Infrared Light", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "MD Stem Cells", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2018-10-24", "completion_date": "2025-07-31", "has_results": false, "last_update_posted_date": "2024-04-15", "last_synced_at": "2026-09-02T17:10:48.377Z", "location_count": 2, "location_summary": "Westport, Connecticut • Coral Springs, Florida", "locations": [ { "city": "Westport", "state": "Connecticut" }, { "city": "Coral Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03724136" }, { "nct_id": "NCT03391765", "title": "An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Progressive Supranuclear Palsy (PSP)" ], "interventions": [ { "name": "ABBV-8E12", "type": "DRUG" }, { "name": "Placebo solution for IV infusion on Day 15", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 142, "start_date": "2018-01-24", "completion_date": "2019-12-13", "has_results": true, "last_update_posted_date": "2021-02-03", "last_synced_at": "2026-09-02T17:10:48.377Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Beverly Hills, California + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03391765" }, { "nct_id": "NCT00703677", "title": "A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Progressive Supranuclear Palsy", "Corticobasal Degeneration" ], "interventions": [ { "name": "Lithium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Westat", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 17, "start_date": "2008-09", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2024-05-17", "last_synced_at": "2026-09-02T17:10:48.377Z", "location_count": 8, "location_summary": "Chicago, Illinois • Louisville, Kentucky • Baltimore, Maryland + 4 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00703677" }, { "nct_id": "NCT01547481", "title": "MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Movement Disorders (Incl Parkinsonism)", "Tremor Familial Essential, 1", "REM Sleep Behavior Disorder" ], "interventions": [], "intervention_types": [], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "19 Years to 85 Years" }, "enrollment_count": 50, "start_date": "2011-12", "completion_date": "2015-12-31", "has_results": false, "last_update_posted_date": "2018-05-17", "last_synced_at": "2026-09-02T17:10:48.377Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01547481" }, { "nct_id": "NCT04715399", "title": "UPenn Observational Research Repository on Neurodegenerative Disease", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Frontotemporal Degeneration(FTD)", "Primary Progressive Aphasia(PPA)", "Familial Frontotemporal Lobar Degeneration (fFTLD)", "Amyotrophic Lateral Sclerosis(ALS)", "Lewy Body Disease(LBD)", "Progressive Supranuclear Palsy(PSP)", "Corticobasal Syndrome(CBS)", "Posterior Cortical Atrophy(PCA)", "Alzheimer's Disease(AD)" ], "interventions": [ { "name": "No intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2020-05-29", "completion_date": "2070-05-30", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-09-02T17:10:48.377Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04715399" }, { "nct_id": "NCT03452956", "title": "Cognitive Impairement In Frontotemporal Dementia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Frontotemporal Degeneration", "Progressive Supranuclear Palsy", "Multiple System Atrophy" ], "interventions": [ { "name": "None-Observation Only", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 997, "start_date": "2003-07-01", "completion_date": "2020-07-15", "has_results": false, "last_update_posted_date": "2020-11-12", "last_synced_at": "2026-09-02T17:10:48.377Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03452956" }, { "nct_id": "NCT06647641", "title": "The CurePSP Genetics Program", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "PSP", "PSP - Progressive Supranuclear Palsy", "Corticobasal Syndrome", "Corticobasal Syndrome(CBS)", "Corticobasal Degeneration Syndrome", "Corticobasal Degeneration", "Corticobasal Degeneration (CBD)", "Corticobasal Syndrome (CBS)", "MSA", "MSA - Multiple System Atrophy", "MSA-C", "Multiple System Atrophy", "Multiple System Atrophy (MSA) With Orthostatic Hypotension", "Multiple System Atrophy - Cerebellar Subtype (MSA-C)", "Multiple System Atrophy - Parkinsonian Subtype (MSA-P)", "Multiple System Atrophy, Cerebellar Type", "Multiple System Atrophy, Parkinsonian Type", "Progressive Supranuclear Palsy", "Progressive Supranuclear Palsy(PSP)", "Progressive Supranuclear Palsy (PSP)" ], "interventions": [ { "name": "Whole genome sequencing will be performed at the NIH", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 1000, "start_date": "2024-10-08", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-09-02T17:10:48.377Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06647641" } ] }